Introduction Metabolic syndrome induces endothelial dysfunction, a surrogate marker of
cardiovascular disease. In parallel, metabolic syndrome is frequently associated with non …

Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic
syndrome. Most morbidity associated with the metabolic syndrome is related to vascular …

Background & Aims Intrahepatic vascular resistance is increased in early non-alcoholic fatty
liver disease (NAFLD), potentially leading to tissue hypoxia and triggering disease …

Nonalcoholic fatty liver disease (NAFLD) is a progressive disease that ranges from simple
steatosis to cirrhosis. Obstructive sleep apnea syndrome (OSAS) and chronic intermittent …

Nonalcoholic fatty liver disease (NAFLD) is one of the most common liver diseases
worldwide. It is strongly associated with obesity, type 2 diabetes (T2DM), and other …

Cholesterol is a pivotal lipotoxic molecule that contributes to the progression of Non-
Alcoholic Steatohepatitis NASH). Additionally, microcirculatory changes are critical …

Background Macrophages engulf oxidized-LDL (oxLDL) leading to accumulation of cellular
cholesterol and formation of foam cells, which is a hallmark of atherosclerosis. Moreover …

Non-alcoholic fatty liver disease (NAFLD) is characterized by excessive storage of fatty acids
in the form of triglycerides in hepatocytes. It is most prevalent in western countries and …

Oxidative stress (OxS) is considered a major factor in the pathophysiology of inflammatory
chronic liver diseases, including non-alcoholic liver disease (NAFLD). Chronic impairment of …

Background Although many factors and molecules that are closely associated with non-
alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) have been …